These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9219315)

  • 1. Nonsteroidal antiinflammatory drugs, ulcers and risk: a collaborative meta-analysis.
    García Rodríguez LA
    Semin Arthritis Rheum; 1997 Jun; 26(6 Suppl 1):16-20. PubMed ID: 9219315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.
    Silverstein FE; Faich G; Goldstein JL; Simon LS; Pincus T; Whelton A; Makuch R; Eisen G; Agrawal NM; Stenson WF; Burr AM; Zhao WW; Kent JD; Lefkowith JB; Verburg KM; Geis GS
    JAMA; 2000 Sep; 284(10):1247-55. PubMed ID: 10979111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variability in risk of gastrointestinal complications with different nonsteroidal anti-inflammatory drugs.
    García Rodríguez LA
    Am J Med; 1998 Mar; 104(3A):30S-34S; discussion 41S-42S. PubMed ID: 9572318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etoricoxib: new drug. Avoid using cox-2 inhibitors for pain.
    Prescrire Int; 2007 Dec; 16(92):223-7. PubMed ID: 18084859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting NSAID related ulcers--assessment of clinical and pathological risk factors and importance of differences in NSAID.
    Taha AS; Dahill S; Sturrock RD; Lee FD; Russell RI
    Gut; 1994 Jul; 35(7):891-5. PubMed ID: 8063215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-steroidal anti-inflammatory drug gastropathy: causes and treatment.
    Hawkey CJ
    Scand J Gastroenterol Suppl; 1996; 220():124-7. PubMed ID: 8898449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The gastrointestinal safety of the COX-2 selective inhibitor etoricoxib assessed by both endoscopy and analysis of upper gastrointestinal events.
    Hunt RH; Harper S; Watson DJ; Yu C; Quan H; Lee M; Evans JK; Oxenius B
    Am J Gastroenterol; 2003 Aug; 98(8):1725-33. PubMed ID: 12907325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal complications of over-the-counter nonsteroidal antiinflammatory drugs.
    Biskupiak JE; Brixner DI; Howard K; Oderda GM
    J Pain Palliat Care Pharmacother; 2006; 20(3):7-14. PubMed ID: 16931473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclo-oxygenase-2 selective inhibitors and nonsteroidal anti-inflammatory drugs: balancing gastrointestinal and cardiovascular risk.
    Moore RA; Derry S; McQuay HJ
    BMC Musculoskelet Disord; 2007 Aug; 8():73. PubMed ID: 17683540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NSAIDs, gastrointestinal toxicity and inflammatory bowel disease.
    Hijos-Mallada G; Sostres C; Gomollón F
    Gastroenterol Hepatol; 2022 Mar; 45(3):215-222. PubMed ID: 34157367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis.
    Henry D; Lim LL; Garcia Rodriguez LA; Perez Gutthann S; Carson JL; Griffin M; Savage R; Logan R; Moride Y; Hawkey C; Hill S; Fries JT
    BMJ; 1996 Jun; 312(7046):1563-6. PubMed ID: 8664664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastroduodenal complications of chronic NSAID therapy.
    Graham DY; Smith JL
    Am J Gastroenterol; 1988 Oct; 83(10):1081-4. PubMed ID: 3048080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recommendation for the prevention and treatment of non-steroidal anti-inflammatory drug-induced gastrointestinal ulcers and its complications].
    ;
    Zhonghua Nei Ke Za Zhi; 2017 Jan; 56(1):81-85. PubMed ID: 28056333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative assessment of the gastrointestinal and cardiovascular risk-benefit of celecoxib compared to individual NSAIDs at the population level.
    Varas-Lorenzo C; Maguire A; Castellsague J; Perez-Gutthann S
    Pharmacoepidemiol Drug Saf; 2007 Apr; 16(4):366-76. PubMed ID: 16897817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-efficiency of nonsteroidal anti-inflammatory drug prescribing in Zagreb, Croatia.
    Vukusić I; Stimac D; Culig J
    Coll Antropol; 2005 Jun; 29(1):143-7. PubMed ID: 16117313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NSAIDs and serious cardiovascular disorders: especially cox-2 inhibitors and diclofenac.
    Prescrire Int; 2016 Jan; 25(167):14-6. PubMed ID: 26942254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonsteroidal antiinflammatory drugs: benefits, risks, and COX-2 selectivity.
    Halverson PB
    Orthop Nurs; 1999; 18(6):21-6; quiz 27-8. PubMed ID: 11062611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of nonsteroidal antiinflammatory drugs on upper gastrointestinal tract symptoms and mucosal integrity.
    Katzka DA; Sunshine AG; Cohen S
    J Clin Gastroenterol; 1987 Apr; 9(2):142-8. PubMed ID: 3553307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
    Limmer S; Ittel TH; Wietholtz H
    Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors associated with the development of gastroduodenal ulcers due to the use of NSAIDs.
    Wolfe MM
    Int J Clin Pract Suppl; 2003 Apr; (135):32-7. PubMed ID: 12723745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.